Steven Howe | VP Process Development
Resolution Therapeutics Ltd

Steven Howe has more than 25 years of experience working in cell and gene therapy, including postdoctoral positions at the UCL Great Ormond Street Institute of Child Health, London, before joining GlaxoSmithKline in 2015 as Senior Director of Product Development leading a team in developing manufacturing processes for advanced therapies. 
During his career Steven has led groups researching a wide range of advanced therapies and technologies to apply them, including viral vectorology, stem cell biology and cell processing. His recent positions have focused on Process Development for manufacturing platforms to translate cell and gene therapies into the clinic, for disease areas including rare diseases, metabolic disorders and cancer.
In his current role at Resolution Therapeutics, he leads the team responsible for developing manufacturing approaches to produce regenerative macrophage therapies to treat inflammatory and fibrotic disease.
Steven has a BSc (hons) in Biology from Bristol University and a PhD from Imperial College, London.